Moolec Science SA Ordinary Shares (MLEC)

Price$7.28

Favorite Metrics

Price vs S&P 500 (26W)-48.16%

Price vs S&P 500 (4W)-20.83%

Market Capitalization$5.28M

All Metrics

Book Value / Share (Quarterly)$10.52

P/TBV (Annual)87.48x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$12.67

Price vs S&P 500 (YTD)85.68%

Gross Margin (TTM)-8.16%

Net Profit Margin (TTM)-105.71%

EPS (TTM)$-26.79

10-Day Avg Trading Volume1.11M

EPS Excl Extra (TTM)$-26.79

EPS (Annual)$-28.96

ROI (Annual)-34.02%

Gross Margin (Annual)8.40%

Cash / Share (Quarterly)$7.26

Revenue Growth QoQ (YoY)948.34%

ROA (Last FY)-21.02%

Revenue Growth TTM (YoY)169.90%

EBITD / Share (TTM)$-0.62

ROE (5Y Avg)-189.55%

Operating Margin (TTM)-116.72%

Cash Flow / Share (Annual)$-37.14

P/B Ratio1.89x

P/B Ratio (Quarterly)11.01x

Net Income / Employee (Annual)$-0

EV / Revenue (TTM)3.38x

Net Interest Coverage (TTM)-2.13x

ROA (TTM)-26.57%

EPS Incl Extra (Annual)$-28.96

Current Ratio (Annual)1.69x

Quick Ratio (Quarterly)0.72x

3-Month Avg Trading Volume1.06M

52-Week Price Return-93.17%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$0.01

P/S Ratio (Annual)0.94x

Asset Turnover (Annual)0.16x

52-Week High$157.05

EPS Excl Extra (Annual)$-28.96

26-Week Price Return-39.42%

Quick Ratio (Annual)0.84x

13-Week Price Return105.95%

Total Debt / Equity (Annual)2.15x

Current Ratio (Quarterly)1.48x

Enterprise Value$26.439

Asset Turnover (TTM)0.25x

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-148.61%

Cash / Share (Annual)$21.10

3-Month Return Std Dev363.36%

Net Income / Employee (TTM)$-0

ROE (Last FY)-107.28%

Net Interest Coverage (Annual)-4.14x

EPS Basic Excl Extra (Annual)$-28.96

Receivables Turnover (TTM)7.07x

EV / Free Cash Flow (TTM)7.85x

Total Debt / Equity (Quarterly)7.90x

EPS Incl Extra (TTM)$-26.79

Receivables Turnover (Annual)1.07x

ROI (TTM)-34.98%

P/S Ratio (TTM)0.67x

Revenue / Share (Annual)$22.28

Tangible BV / Share (Annual)$0.04

Price vs S&P 500 (52W)-128.27%

Year-to-Date Return89.82%

5-Day Price Return-3.32%

EPS Normalized (Annual)$-28.96

ROA (5Y Avg)-71.45%

Net Profit Margin (Annual)-129.99%

Month-to-Date Return22.80%

Cash Flow / Share (TTM)$-1.55

EBITD / Share (Annual)$-19.09

Operating Margin (Annual)-160.76%

LT Debt / Equity (Annual)1.72x

P/CF (TTM)1.45x

ROI (5Y Avg)-153.62%

LT Debt / Equity (Quarterly)6.93x

EPS Basic Excl Extra (TTM)$-26.79

P/TBV (Quarterly)202.91x

P/B Ratio (Annual)6.97x

Inventory Turnover (TTM)3.17x

Pretax Margin (TTM)-110.09%

Book Value / Share (Annual)$26.68

Price vs S&P 500 (13W)103.08%

Beta-0.18x

P/FCF (Annual)5.39x

Revenue / Share (TTM)$30.16

ROE (TTM)-150.93%

52-Week Low$3.07

Analyst Recommendations

Apr 2025

May 2025

Jun 2025

Jul 2025

4.14

Industry Peers(1)

Symbol	P/E Ratio (Annual)	ROE (TTM)	Revenue Growth (5Y)	Indicated Dividend Yield (Annual)	Price
MLECMoolec Science SA Ordinary Shares	—	-150.93%	—	—	$7.28
UFIUNIFI, Inc. New	—	-9.44%	-1.19%	—	$3.73

About

Moolec Science SA uses molecular farming technology to produce animal proteins in plants for the alternative protein market. The company develops specialty ingredients including textured plant proteins and functional oils designed to improve taste, nutrition, and cost-effectiveness of meat alternatives. Based in Argentina, Moolec positions its technology as a sustainable solution for scaling alternative protein production.